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Effects of dietary protein in patients with chronic renal transplant
rejection. Dietary protein restriction reduces proteinuria and slows the
progression of renal failure in a variety of renal diseases in native
kidneys. Such beneficial effects may be mediated by the multiple renal
effects of dietary protein including those on glomerular capillary hemo-
dynamics and the renin-angiotensin system. The role of dietary protein
restriction in the management of chronic renal transplant rejection is,
however, unclear. This study was therefore undertaken to examine the
effects of dietary protein restriction in patients with chronic rejection.
Fourteen patients with biopsy proven chronic rejection, who had been
on a self-selected home diet of 1.0 0.1 g protein/kg/day, were
randomly assigned, using a crossover design to two 11-day periods, one
on a low protein diet (0.55 g/kg/day) and the other on a high protein diet
(2 g/kg/day). The effect of these diets on renal hemodynamics, protein-
uria, plasma renin activity, and nutritional status was examined. The
low protein diet was associated with a significant improvement in
glomerular permselectivity in all patients as evidenced by a significant
fall in the fractional clearance of albumin and IgG and reduction in
24-hour urinary excretion of total protein, albumin and IgG without any
change in blood pressure, glomerular filtration rate, or renal plasma
flow. Compared to the proteinuria at the beginning of each diet, a high
protein diet did not increase but a low protein diet significantly
decreased the proteinuria. The low protein diet was also associated with
a significant reduction in plasma renin activity, suggesting that part of
the beneficial effect of protein restriction was related to the suppression
of the renin-angiotensin system. Protein restriction was also associated
with modest but significant falls in serum proteins. In conclusion, a low
protein diet reduces proteinuria and lowers plasma renin activity in
patients with chronic rejection, Dietary protein restriction may improve
the course of renal failure in chronic rejection partly by suppressing the
renin-angiotensin system. Studies are needed to establish the safe level
of dietary protein restriction in these patients and to assess the efficacy
of such restriction in slowing the progression of renal failure.
Chronic rejection is the most common cause of late renal
allograft failure [1—3]. Since no specific therapy exists, chronic
rejection usually leads to progressive and unrelenting destruc-
tion of the transplanted kidney [3]. As the number of these late
failing allografts rise, chronic rejection is becoming an increas-
ingly common cause of end-stage renal failure.
Although immunologic mechanisms play a central role in
failure of the renal allograft, a component of the progressive
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loss of renal function may be related to initially adaptive but
eventually maladaptive functional and structural alterations
which are common to many progressive renal diseases [4]. Low
protein diets can reduce proteinuria and may slow the rate of
progression of renal failure in native kidneys [5—8]. Such
beneficial effects of protein restriction may derive from the
ability of low protein diets to suppress the renin-angiotensin
system and blunt the deleterious adaptive responses to nephron
loss including effects on glomerular capillary hemodynamics,
renal growth, ammoniagenesis, and metabolic rate [5, 9—13]. If
these responses play a role in the progression of chronic
rejection, then dietary protein restriction would be a potentially
beneficial therapeutic option in this otherwise untreatable con-
dition.
The role of dietary protein restriction in the treatment of
chronic transplant rejection is uncertain. We therefore under-
took this study to examine the short-term renal, hormonal, and
nutritional responses to dietary protein in patients with biopsy-
proven chronic renal transplant rejection.
Methods
Patient population
Fourteen patients were recruited from the renal transplant
population at the University of Minnesota. Eligibility criteria
included a transplant biopsy showing clear histological evi-
dence of chronic rejection (intimal proliferative arterial disease,
tubular epithelial atrophy, interstitial fibrosis) or transplant
glomerulopathy without evidence for acute rejection or recur-
rence of the original renal disease. The subjects also had
proteinuria (2.0 0.6 glday), a serum creatinine value between
133 and 442 ,&mollliter (1.5 and 5 mgldl) at the time of entry into
the study, and either bilateral nephrectomy of the native
kidneys or the absence of proteinuria on urinalysis one month
post-transplant to rule out the native kidneys as a source for the
proteinuria. Additional entry criteria required the patients to
have stable immunosuppressive treatment and no therapy with
an angiotensin converting enzyme inhibitor for the two months
preceding the study.
Characteristics of the study population are presented in Table
1. All patients were on antihypertensive treatment. Drugs were
not changed during the two dietary study periods, except in one
patient whose dose of nifedipine was increased on the low
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Table 1. Characteristics of the study population
Characteristic Patient
Sex (in/f) 7/7
Age years 37 4
Primary renal disease
Chronic glomerulonephritis 8
Diabetic nephropathy 3
Unknown 3
Immunosuppressive drugs
Cyclosporine N = 9; mg/day 156 29
Azathioprine N = 13; mg/day 154 7
Prednisone N = 14; mg/day 14 1
Time since transplant months 77.4 14.2
Chronic renal transplant rejection was confirmed in all 14 patients by
allograft biopsy.
protein period to control blood pressure. The study was con-
ducted in the General Clinical Research Centre (GCRC) at the
University of Minnesota. Informed consent was obtained from
the patients prior to the study which was approved by the
Human Subjects Committee at the University of Minnesota.
Diet
A constant research diet was employed with a two-day cycle
menu [5]. Regular and low protein food products were used;
their nutrient composition was calculated using the United
States Department of Agricultural Handbook No. 8, manufac-
turer's nutrient analysis data, or laboratory data for selected
food items. The food products were weighed to g and
prepared according to standardized food preparation proce-
dures for research diets. The protein content of the low protein
diet was 0.55 glkg/daywith 75% as high biological value protein.
This level of protein restriction is consistent with neutral
nitrogen balance in normal individuals [14]. The high protein
diet contained 2 g/kglday of protein. Both diets were supple-
mented gram for gram by the 24-hour urinary protein loss
measured prior to entry into the study. The diets were con-
trolled for sodium at 80 mmol/day, potassium at 100 mmol/day,
phosphorous at 2 glday and calories at 35 kcal/kg/day. Carbo-
hydrate calories substituted for protein calories on the low
protein diet. Potassium and phosphorous were supplemented as
potassium phosphate where necessary. Free access to water
was allowed.
Study protocol
A crossover design was used consisting of two 11-day periods
during which all subjects were inpatients at the GCRC. By
random assignment, seven patients were started on the low
protein diet and seven patients on the high protein diet. The two
dietary periods were intentionally separated by an interval of
one to four weeks to minimize any carry-over effects of the
diets, and at the same time to avoid any significant progression
in their underlying renal disease. Prior to the start of each
dietary period the subjects collected a 24 hour urine to allow for
comparison of urinary measurements on their regular home diet
to those at the end of the low and high protein diets ingested in
the GCRC.
Daily weights, twice daily blood pressures, and in the diabet-
ics, at least twice daily blood sugars were measured. Insulin
doses were adjusted in the diabetics to maintain optimum blood
sugar control. On the morning of day 11 of each dietary period,
renal clearance studies were performed as previously described
[5]. At 9 a.m. an intravenous priming dose followed by a
constant infusion of inulin (Iso-Tex Diagnostics, Friendswood,
Texas, USA) and p-aminohippurate (PAH; Merck Sharpe &
Dohme, West Point, Pennsylvania, USA) was administered in
one forearm. The continuous infusion of inulin and PAH were
designed to maintain blood levels of 25 mg/dl and 2 mg/dl,
respectively. Blood samples were collected from a heparinized
cannula positioned in the forearm contralateral to the infusion.
To ensure accurate urine collection, urinary catheters were
placed in two diabetic patients with prior difficulty in voluntary
voiding. The subjects drank 500 ml of water per hour during the
clearance period to ensure adequate urine output. Blood pres-
sure and a blood sample for measurement of inulin and PAH
were obtained at the midpoint of each clearance period. The
average value for inulin and PAH clearances during these two
periods was considered to represent GFR and RPF, respec-
tively. RPF was corrected for published values of extraction
ratio for patients with renal disease by dividing the PAH
clearance by 0.7 [15].
Changes in glomerular permselectivity were investigated by
measuring urinary excretion of total protein, albumin and IgG in
the 24 hour urine collected at home, and on the last day of each
diet. In addition, the fractional clearances of two endogenous
proteins of different sizes, albumin (36 A) and IgG (55 A), were
measured on the final day of each diet. Fractional clearances
were calculated as the quotient of the urinary clearances of
protein and the filtration marker, inulin. Since urinary protein
excretion can be influenced by tubular protein reabsorption, we
used the tubular reabsorption rate of f32-microglobulin as an
index of tubular reabsorption of protein. /32-microglobulin re-
absorption rate was calculated by subtracting the amount
excreted from the filtered load, assuming that this small radius
protein (16 A) encounters no restriction to filtration.
Nitrogen balance was estimated using the following formula:
Nitrogen balance = Nitrogen(1fl) — Nitrogen(ol)
where Nitrogen(J) was derived by dividing the calculated
protein intake (g/day) by 6.25, and Nitrogen(0) was calculated
from the following formula:
Nitrogen(o) = UUN + 0.031 glkg/day
+ change in urea nitrogen pool
where UUN is the urinary urea nitrogen excretion and 0.03 1
glkg/day provides an estimate of fecal and non-urea urinary
nitrogen loss [16]. Change in urea nitrogen pool was calculated
as follows:
[weight (kg) X BUN X °6]Day — {weight (kg) x BUN
X O.6]Day 10
where 0.6 was assumed to represent the volume of distribution
of urea [16].
Plasma renin activity was measured on day 10 of each dietary
period. Samples were drawn at 7 a.m. after overnight fasting
and recumbency, and between 9 and 10 a.m. after one hour of
ambulation.
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Urine and heparinized plasma were used for colorimetric
measurements of inulin and PAH as in our previous study [51.
Albumin, transferrin, prealbumin, and IgG were measured by
rate nephelometry (Beckman Immunochemistry System, Beck-
man Instruments, Brea, California, USA). Total protein was
measured by the biuret technique. An enzyme immunoassay
(Phadezym /32-microTest, Pharmacia Diagnostics) was used to
determine f32-microglobulin. Serum sodium, potassium, chlo-
ride, bicarbonate, glucose, calcium, urea nitrogen, creatinine,
and urine sodium, potassium, urea nitrogen, and creatinine
were measured by an autoanalyzer (Beckman ASTRA). Hemo-
globin and white blood cell count were determined by a Coulter
counter. Cholesterol, triglyceride and phosphorus were mea-
sured by enzyme colorinietric assays. Plasma renin activity was
determined by radioimmunoassay for angiotensin I at pH 5.7
using a commercially available kit (DuPont Diagnostic Imaging,
North Billerica, Massachusetts, USA).
Statistics
All data are reported as mean standard error of the mean.
Statistical differences were calculated by either the Student's
paired t-test or the Wilcoxon signed rank test depending on
whether the values were normally distributed or not. A statis-
tical significant difference between values was considered for a
P value of <0.05.
Results
General parameters
The calculated protein intake of the subjects self-selected
home diets was similar prior to the start of the low and high
protein diet with respective values of 69 6 g/day (1.0 0.1
g/kglday) versus 67 6 g/day (1.0 0.1 g/kg/day). The average
daily protein intake on the low and high protein diets was 41
2 and 145 8 g/24 hr. The amount of fat in the two diets was
quantitatively similar (low protein: 106 7 vs. high protein: 106
6 g124 hr). Since the caloric content of the diets was similar
(low protein: 2430 119 vs. high protein: 2458 119 Kcal/24
hr), the carbohydrate content of the diets differed being higher
on the low protein diet (low protein: 347 14 vs. high protein:
230 10 g/24 hr). Over the short period of this study, the low
protein diet was readily accepted by all the patients whereas
most patients became intolerant, but still compliant, with the
high protein diet.
The serum urea nitrogen, measured at the beginning and at
end of each dietary period, reflected the different protein
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Table 3. Renal hemodynamics measured on th
dietary period
e final day of each
High protein diet Low protein diet
GFR mI/mini) .73 m2 27 4 25 4
RPF mlimin/1.73 m2 121 14 102 11
Filtration fraction 0.24 0.02 0.25 0.02
Values are mean SEM. No statistical differences were present.
intakes (low protein day 0: 18.6 2.5 vs. day 11: 10.7 1.8
mmol/liter; high protein day 0: 19.3 2.1 vs. day 11: 34.3 3.6
mmollliter; Table 2). Similarly, changes in urine urea nitrogen
were consistent with the different protein content of the diets
(Table 2). Urine sodium and potassium excretion was not
significantly different on the two diets reflecting similar intakes
as planned (Table 2). Serum bicarbonate (20 1 vs. 25 1
mmollliter) and potassium (3.5 0.2 vs. 4.0 0.1 mmoliliter)
were significantly lower and creatinine (310 36 vs. 284 36
mol/liter) was significantly higher on the high protein diet.
These changes in bicarbonate and creatinine levels on the high
protein diet are likely related to the increased acid and creati-
nine load associated with the high meat ingestion. The lower
serum potassium may have been secondary to internal shifts, or
to increased urinary excretion secondary to solute diuresis, the
presence of unreabsorbable anion, and/or increased aldosterone
secretion. Since urine potassium was only measured on the final
day of the diets the exact mechanism can not be elucidated. No
significant changes in body weight or hematocrit (Table 2), or
serum sodium, chloride, calcium (corrected for changes in
serum albumin), phosphorus, cholestrol, triglyceride or glucose
(data not shown) were observed between the diets.
Hemodynamics
Mean arterial pressure, the mean values of daily 7 a.m. and 7
p.m. blood pressure, was similar throughout the study (Fig. I).
GFR, RPF, and filtration fraction were not significantly dif-
ferent between the two dietary periods (Table 3).
Proteinuria
Twenty-four hour urinary excretion of total protein, albumin
and IgG were significantly lower at the end of low protein diet
compared to the high protein diet with decreases of 33%, 38%
and 50%, respectively (Fig. 2). Urinary IgG was below the
limits of detectability of the assay in one patient. When com-
pared to the values obtained at the start of each dietary period,
Table 2. General parameters measured on the final day of each
dietary period
High protein diet Low protein diet
Weight kg
Hematocrit
Serum urea nitrogen mmol/iiter
Urine urea nitrogen mmollday
Urine sodium mmoliday
Urine potassium mmoi/day
69.0 3.5
0.30 0.02
34.3 3.6
595 54
71 775 4
70.0 3.4
0.30 0.02
10.7 l.8a
17! 16
69 6
68 3
100
Values are mean SEM.
ap <0.01
Laboratory measurements
0 2 4 6 8 10
Day
Fig. 1. Mean arterial pressure measured twice daily while the patients
were ingesting low (open circle) and high protein diets (closed circle).
Values are mean SEM. No statistical differences were present.
Fig. 2. Twenty-four-hour urinary excretion of
total protein (A) and albumin (B) measured in
14 patients and IgG (C) measured in 13
patients at the end of each dietary period.
Alsogiven is the mean SEM in vertical bars.
High and Low refer to high and low protein
High Low diets. p < 0.05.
Table 4. Urinary protein excretion at the start (day 0) versus the final day (day 11) of each dietary period
High protein diet Low protein diet
Day 0 Day 11 Day 0 Day 11
Urine total protein glday
Urine albumin glday
Urine IgG glday
2.17 0.56
1.83 0.39
0.07 0.02
1.95 0.42
1.39 0.35
0.08 0.02
2.30 0.05
1.49 0.45
0.08 0.02
1.31 0•35a,b
0.86 0.23
0.04 001a.b
Values are mean SEM. No statistical differences were present between values on Day 0 of high protein diet vs. values on Day 0 of low protein
diet. Day 0 values were measured by a 24 hour urine specimen, collected at home while the subject had been on a regular home diet.
P < 0.05 vs. Day 0 values of respective dietb P < 0.05 vs. Day 11 of high protein diet
a significant decrease in the excretion of total protein, albumin
and IgG occurred on the low protein diet, whereas no change in
the excretion of these proteins was seen on the high protein diet
(Table 4). Thus, a low protein diet decreased proteinuna while
a high protein diet had no additional proteinuric effect com-
pared to the more intermediate levels of protein intake on the
subjects home diet.
To account for the effects of changes in serum protein levels
and GFR, fractional clearance of albumin and IgG were calcu-
lated on the final day of the low and high protein diet. On the
low protein diet the fractional clearance of both these proteins
fell in all subjects (Fig. 3). The fractional clearance of albumin
decreased by 43% (24.99 6.38 vs. 14.16 4.31 X l0; P <
0.01) and IgG by 60% (9.09 1.95 vs. 3.68 1.31 X l0; P <
0.001). To rule out changes in protein reabsorption as a cause
for the decrease in protein excretion, the renal handling of
/32-microglobulin was examined. The tubular reabsorption rate
and fractional clearance of f32-microglobulin were similar at the
end of the low and high protein diets (127 14 vs. 152 14
g/min; P NS) and (0.10 0.03 vs. 0.08 0.02 tgImin; P =
NS). Thus the decrease in fractional clearance of albumin and
IgG on the low protein diet was consistent with an improvement
in glomerular permselectivity without apparent change in pro-
tein reabsorption.
Hormonal changes
The plasma renin activity was significantly higher on the high
protein diet in both the supine and standing position (Fig. 4).
The mean values for the high and low protein diets, respec-
tively, were 12.7 3.0 versus 5.4 1.8 ng Ang I/mi/hr (supine;
P <0.05), and 17.1 4.1 versus 9.0 2.3 ng Ang I/mi/hr (erect;
P < 0.05).
Nutritional parameters
Nutritional parameters, measured on the final day of each
dietary period, are presented in Table 5. Serum total protein,
albumin and transferrin were significantly lower at the end of
low protein diet compared to the high protein diet. Serum IgG
and prealbumin also tended to be lower on the low protein diet.
No difference in body weight or blood lymphocyte counts was
found. The calculated nitrogen balance on the final day of the
low and high protein diet was +0.13 0.45 and +5.94 1.78 g,
respectively.
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Fig. 3. Fractional clearance of albumin (A)
measured in 14 patients and IgG (B)
measured in 13 patients at the end of each
dietary period. Also given is the mean SEM
in vertical bars. High and Low refer to high
and low protein diets. < 0.01.
Discussion
Chronic rejection is the leading cause of late renal allograft
failure accounting for up to 80% of late graft loss [1—3]. Since no
effective therapy is available, chronic rejection inevitably pro-
gresses to terminal renal failure prompting either a return to
dialysis or retransplantation. In fact, as the cumulative number
of renal transplants increase, chronic rejection is becoming an
increasingly common cause of end-stage renal failure. A trans-
plant recipient, dependent on a solitary kidney, begins with
reduced renal mass. Any additional loss in renal mass by the
immunological rejection process may promote hemodynamic
and structural adaptive responses in the remaining nephrons
that may eventually contribute to the progression of renal
failure in chronic rejection. Indeed, experimental studies in
animal models of chronic rejection have reported elevated
glomerular pressure, glomerular hypertrophy, proteinuria and
focal segmental glomerulosclerosis, features characteristic of
hemodynamically-mediated renal injury [4, 17, 18]. Further-
more, patients with established chronic rejection display more
rapid decay of renal function with elevated arterial pressure
[19]. Effective strategies for slowing the progression of renal
disease in native kidneys have included aggressive antihyper-
tensive therapy and dietary protein restriction [6-8, 20]. Simi-
larities between the pathophysiology of renal disease progres-
sion in native and transplanted kidneys suggest that these
therapies could also be effective in the chronically rejecting
kidney.
In this randomized controlled crossover study, we demon-
strated that changes in dietary protein intake were associated
with alterations in glomerular permselectivity, plasma renin
activity and serum proteins without any change in blood pres-
sure, GFR or RPF. Specifically, protein restriction improved
glomerular permselectivity as evidenced by a reduction in the
24-hour urinary excretion of total protein, albumin, and IgG as
well as the fractional clearance of albumin and IgG. The
improvement in glomerular permselectivity with the low protein
diet was associated with lower plasma renin activity. This
short-term protein restriction to a level of 0.55 g/kg/day, was
also associated with a fall in serum protein levels.
The reduction in proteinuria on the low protein diet was
unlikely due to changes in blood pressure or tubular reabsorp-
tion of proteins, since both blood pressure and renal handling of
f32-microglobulin, which was used as a marker of tubular
protein reabsorption, were similar on both diets. The beneficial
effect of the low protein diet was almost universal with a
reduction in 24-hour urinary excretion of total protein, albumin,
IgG, and fractional clearance of albumin and IgG occurring in
almost all patients regardless of level of proteinuria or GFR.
Furthermore, the beneficial effect of the low protein diet in
reducing proteinuria was apparent not only when compared to
the level of proteinuria observed at the end of the high protein
diet, but the beneficial effect was also observed when compared
to the level of proteinuria present at the start of the study when
patients were ingesting their regular home diet (1 glkglday of
protein). Part of the reduction in proteinuria at the end of low
protein diet may have been due to effects of hospitalization.
However, all patients were ambulatory and active during their
stay in the GCRC, and their inpatient blood pressure control
was not different from the blood pressure at admission. Thus, a
reduction in proteinuria was noted when dietary protein was
decreased from I to 0.55 g/kg/day, whereas increasing the
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Fig. 4. Plasma renin activity measured in
supine (A) and erect (B) positions at the end
of each dietary period in 13 Patients. Also
given is the mean SEM in vertical bars.
High and Low refer to high and low protein
Low diets. *D < 0.01.
dietary protein content from 1 to 2 glkg/day was not associated
with any significant increase in proteinuria (Table 4).
The relatively short dietary period employed in this study
allowed for rigorously controlled diets, ensured excellent di-
etary compliance and permitted a crossover design which
allowed patients to serve as their own controls. Although we
could not, by design and duration, assess the effects of dietary
protein on long-term changes in GFR or progression, changes in
proteinuria do provide a useful quantitative prognostic index.
The lower urinary excretion of total protein and in particular of
large molecular weight proteins such as IgG, as was seen on the
low protein diet, signifies an improvement in the size-selective
defect in glomerular permselectivity [211. Such an improvement
in permselectivity correlates with higher glomerular filtration
rates, less severe histological patterns, and response to treat-
ment [22.-24]. Improvement in size selective defects have
occurred with successful immunosuppressive treatment of lu-
pus nephritis, with resolution of the nephrotic syndrome, and
following long-term dietary protein restriction [7, 8, 21, 25].
Although the decrease in protein excretory rates and improve-
ment in size selectivity demonstrated on the low protein diet is
a positive prognostic marker and suggests dietary protein
restriction may improve the course of chronic renal transplant
rejection, caution must be exercised in extrapolating our short-
term findings to long-term outcome. However, slowing of
progression of renal failure with dietary protein restriction has
been demonstrated in small groups of patients with chronic
renal transplant rejection [26, 27].
The exact mechanism by which dietary protein restriction
improves glomerular permselectivity and lowers proteinuna in
humans is unclear. The rapid reduction in proteinuna on the
low protein diet suggests that alterations in glomerular hemo-
dynamics may play an important role. Changes in glomerular
capillary pressure may directly alter the glomerular capillary
barrier with a reduction in glomerular pressure being associated
with an improvement in permselectivity and a fall in urinary
protein excretion [28]. When a low protein diet has been
imposed after the establishment of renal failure in rats with
subtotal nephrectomy, a decrease in proteinuria was found [12].
This effect was associated with a reduction in glomerular
pressure due primarily to decreased efferent arteriolar resis-
tance but no change in GFR or RPF. The stability of GFR and
RPF despite the varying protein intakes was accounted for by
the respective off-setting changes in the ultrafiltration coeffi-
cient and decrease in efferent arteriolar resistance. Our patients
with chronic rejection also showed no significant change in
GFR or RPF with change in the dietary protein content of their
diets. Furthermore, in our previous study using a similar
protocol, we observed no difference in GFR or RPF between
high and low protein diets in patients with non-transplant renal
disease [5]. Thus, the finding of similar GFR and RPF with
different protein intakes is consistent with those of previous
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Table 5. Nutritional parameters measured on the final day of each
dietary period
High protein
diet
Low protein
diet
Serum total protein glliter 59 2 54 ia
Serum albumin glliter 33 1 30 ia
Serum IgG glliter 7.24 0.09 6.84 0.08
Serum prealbumin g/liter 0.45 0.03 0,36 0.03
Serum transferrin glliter 2.44 0.12 2.11 o.l1
Blood lymphocyte count iOIi 1.53 0.29 1.53 0.26
Estimated nitrogen balance glday 5.94 1.78 0.13 0.45
Values are mean SEM.
aP < 0.05
experimental and human dietary protein studies, yet is compat-
ible with reductions in glomerular capillary pressure, though
human studies do not permit direct assessment of glomerular
pressure.
Plasma renin activity was higher in these patients with
chronic rejection compared to healthy subjects or patients with
non-transplant renal disease ingesting similar high and low
protein diets [5, 29]. Although chronic rejection with its atten-
dant intrarenal arteriolar narrowing may have been responsible
for the elevated renin [30, 31], other possibilities include
diuretic therapy and/or increased renin production from the
native kidneys.
The reduction in proteinuria with dietary protein restriction
may involve the interaction between the renin-angiotensin
system and dietary protein. Plasma renin activity varies directly
with the level of dietary protein with decreased plasma renin
activity on a low protein diet being seen in normal rats [9] and
humans [29] and in patients with non-transplant renal disease
[5]. Protein intake is directly related to the steady state level of
renin mRNA suggesting an effect on renin synthesis [10]. The
higher plasma renin activity seen with higher protein ingestion
may play a role in worsening the glomerular permselective
defects by increasing glomerular pressure through the prefer-
ential tonic effect of Ang II on the efferent arterioles [32]. That
the interaction between the renin-angiotensin system and di-
etary protein modulates glomerular permselectivity and hence
proteinuria, is supported by studies which have demonstrated
an improvement in permselectivity with inhibition of Ang II, an
effect that is especially notable on higher protein diets [33—35].
Our results demonstrating a reduction in proteinuria with a low
protein diet in association with lower plasma renin activity
support an interaction between the renin-angiotensin system
and dietary protein in modulating glomerular permselectivity in
patients with chronic renal transplant rejection. Perhaps, the
beneficial effect of dietary protein restriction in this condition
can in part be attributed to suppression of the renin-angiotensin
system.
The lowering of serum proteins with 0.55 g/kg/day of protein
restriction in this study was in contrast to our previous findings
in patients with non-transplant renal disease where serum
proteins remained stable despite a similar degree and duration
of protein restriction [5]. The fall in serum proteins was modest
and did not reach statistical significance for serum IgG and
transferrin. Also, body weight and lymphocyte count were not
affected by the low protein diet. However, patients with chronic
rejection receiving corticosteroid therapy may have a higher
rate of protein catabolism [36]. During the acute post-transplant
period, when patients are recovering from the stresses of
surgery and are on high dose steroid therapy, protein require-
ments are elevated [37, 38]. Less is known about protein
requirements during the more chronic post-transplant period
when steroid dose is reduced. A decrease in muscle mass has
been found in stable renal transplant patients on maintenance
prednisone [39, 40]. However, a recent report suggests that
nitrogen balance can be maintained on a low protein intake (0.6
g/kg/day) in this group of patients provided adequate caloric
intake (>25 kcal/kg/day) is maintained [41]. Although estimates
of final day nitrogen balance in this study did not reveal
negative nitrogen balance in subjects ingesting the low protein
diet, the fall in serum proteins suggests these patients may have
been in negative nitrogen balance prior to the balance measure-
ment. More formal nitrogen balance studies at other time points
would be necessary to establish the safe level of dietary protein
restriction in patients with chronic rejection.
In summary, under controlled conditions, a low protein diet
improved glomerular permselectivity with attendant reduction
in proteinuria. The antiproteinuric effect of the low protein diet
was associated with a lower plasma renin activity suggesting
part of the beneficial effects of a low protein diet was related to
suppression of the renin-angiotensin system. Dietary protein
restriction of 0.55 gfkg/day was associated with a fall in serum
proteins suggesting that patients with chronic rejection may
require a higher minimum protein intake to maintain nutritional
balance. Our short-term study suggests that modest dietary
protein restriction may improve the course of chronic rejection
and that strategies useful in slowing the progression of renal
disease in native kidneys may prove successful in chronic
rejection. Trials are clearly needed to establish the safe level of
dietary protein restriction and to assess the long-term efficacy
of protein restriction on the progression of chronic rejection
before dietary protein restriction can be recommended as a
treatment option for patients with chronic rejection.
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